Skip to Content
Merck

Key Documents

View All Documentation

Skip To

B6769

des-Arg9-[Leu8]-Bradykinin acetate salt

≥97% (HPLC)

Synonym(s):

Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
25 mg
Please contact Customer Service for Availability
€419.00
€314.25

About This Item

Empirical Formula (Hill Notation):
C41H63N11O10
CAS Number:
115035-45-5
Molecular Weight:
870.01
UNSPSC Code:
12352209
PubChem Substance ID:
329773283
NACRES:
NA.26
MDL number:
MFCD00133250

€314.25

List Price€419.00Save 25%
Web-Only Promotion
Please contact Customer Service for Availability
​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

des-Arg9-[Leu8]-Bradykinin acetate salt, ≥97% (HPLC)

Quality Level

200

assay

≥97% (HPLC)

form

powder

color

white

storage temp.

−20°C

SMILES string

CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@@H](N)CCCNC(N)=N)C(O)=O

InChI

1S/C41H63N11O10.C2H4O2/c1-24(2)20-28(40(61)62)48-36(57)31-14-8-17-50(31)38(59)29(23-53)49-34(55)27(21-25-10-4-3-5-11-25)47-33(54)22-46-35(56)30-13-7-18-51(30)39(60)32-15-9-19-52(32)37(58)26(42)12-6-16-45-41(43)44;1-2(3)4/h3-5,10-11,24,26-32,53H,6-9,12-23,42H2,1-2H3,(H,46,56)(H,47,54)(H,48,57)(H,49,55)(H,61,62)(H4,43,44,45);1H3,(H,3,4)/t26-,27-,28-,29-,30-,31-,32-;/m0./s1

InChI key

XBFMNOKHQZCARQ-XXZMQFNDSA-N

Application

The Bradkykinin amid peptide des-Arg9-[Leu8]-Bradykinin is used as a bradykinin-1 receptor (B1R) antagonist frequently in comparison with the B1 receptor agonist des-Arg9-bradykinin.

Biochem/physiol Actions

Bradykinin receptor antagonist.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
89064T0273B2133
des-Arg9-[Leu8]-Bradykinin acetate salt ≥97% (HPLC)

Sigma-Aldrich

B6769

des-Arg9-[Leu8]-Bradykinin acetate salt

4-Phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg trifluoroacetate salt ≥95% (HPLC)

Sigma-Aldrich

89064

4-Phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg trifluoroacetate salt

N-p-Tosyl-Gly-Pro-Arg 7-amido-4-methylcoumarin hydrochloride protease substrate

Sigma-Aldrich

T0273

N-p-Tosyl-Gly-Pro-Arg 7-amido-4-methylcoumarin hydrochloride

N-Benzoyl-Pro-Phe-Arg-p-nitroanilide hydrochloride protease substrate

Sigma-Aldrich

B2133

N-Benzoyl-Pro-Phe-Arg-p-nitroanilide hydrochloride

form

powder

form

powder

form

powder

form

powder

assay

≥97% (HPLC)

assay

≥95% (HPLC)

assay

≥98% (TLC)

assay

≥97% (HPLC)

storage temp.

−20°C

storage temp.

-

storage temp.

−20°C

storage temp.

−20°C

color

white

color

-

color

-

color

-

Quality Level

200

Quality Level

100

Quality Level

200

Quality Level

200

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SLBN8619V
SLBL2111V
SLBC4682V
011M5053
039K5016

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Juliano Ferreira et al.
Neuropharmacology, 54(3), 597-604 (2008-01-01)
The peripheral injection of phorbol myristate acetate (PMA) into the mouse paw induces nociception mediated through activation of protein kinase C (PKC). In the present study, we examine the contribution of kinin B1 receptor to PMA-induced nociception. Nociception was assessed
Thomas A Barker et al.
Hypertension (Dallas, Tex. : 1979), 48(5), 942-949 (2006-09-20)
It has been suggested that the effects of angiotensin II type 1 receptor (AT1R) blockers are in part because of angiotensin II type 2 receptor (AT2R) signaling. Interactions between the AT2R and kinins modulate cardiovascular function. Because AT2R expression increases
M M Campos et al.
British journal of pharmacology, 117(5), 793-798 (1996-03-01)
1. The effect of pretreatment with bacterial endotoxin (LPS, 10 micrograms, i.v., 24 h) on the bradykinin B1 and B2 receptor-induced oedema in the rat paw, and the interaction of B1-mediated responses with other inflammatory mediators, was investigated. 2. Intraplantar

Global Trade Item Number

SKUGTIN
B6769-25MG04061833435809

Questions

Reviews

No rating value

Active Filters